{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:52:13Z","timestamp":1770486733860,"version":"3.49.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0100651","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T20:26:40Z","timestamp":1403728000000},"page":"e100651","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"ntr3521","registry":"10.18810\/dutch-trial-register"}],"author":[{"given":"Susanne P.","family":"Stoof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona R. M.","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie M.","family":"van Rooijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A. M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy A. M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-7954-11-17","article-title":"Global epidemiology of invasive meningococcal disease","volume":"11","author":"RZ Jafri","year":"2013","journal-title":"Popul Health Metr"},{"key":"ref2","unstructured":"Neppelenbroek SE, de Vries M, de Greeff SC, Timen A (2003) \u201cDa&apos;s goed gedaan?\u201d Report of the Dutch national vaccination campaign against meningococcal serogroup C disease in 2002. Utrecht: Municipal and Regional Health Service (GGD), The Netherlands."},{"key":"ref3","unstructured":"van Lier EA, Oomen PJ, Mulder M, Conyn-van Spaendonck MAE, Drijfhout IH, et al. (2013) Vaccinatiegraad Rijksvaccinatieprogramma Nederland: Verslagjaar 2013 Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Bilthoven, Nederland."},{"key":"ref4","unstructured":"van &apos;t Klooster T, de Melker H (2013) The National Immunisation Programme in the Netherlands: Developments in 2012. Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. 201001002\/2012."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"MC Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/aje\/kwi160","article-title":"Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination","volume":"162","author":"CL Trotter","year":"2005","journal-title":"Am J Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"H Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"MC Maiden","year":"2002","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs","volume":"8","author":"CL Trotter","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"CL Trotter","year":"2004","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"R Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e12144","DOI":"10.1371\/journal.pone.0012144","article-title":"Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine","volume":"5","author":"RM de Voer","year":"2010","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/INF.0b013e3181f728fd","article-title":"Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial","volume":"30","author":"A Khatami","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine","volume":"24","author":"MD Snape","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"G Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1016\/j.vaccine.2009.09.082","article-title":"Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults","volume":"27","author":"RM de Voer","year":"2009","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2008.02934.x","article-title":"Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine","volume":"127","author":"DF Kelly","year":"2009","journal-title":"Immunology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization","volume":"43","author":"MD Snape","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999\u20132000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"KP Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/archdischild-2013-303893","article-title":"Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination","volume":"98","author":"PC de Whalley","year":"2013","journal-title":"Arch Dis Child"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"MD Snape","year":"2008","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1097\/INF.0b013e318224fb14","article-title":"Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine","volume":"30","author":"PC de Whalley","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref23","unstructured":"European Centre for Disease Prevention and Control, Vaccine Scheduler (Acces date: January 6, 2014) available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx\" xlink:type=\"simple\">http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx<\/ext-link>."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"SE Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"N Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"R Borrow","year":"2005","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1128\/CVI.00478-07","article-title":"Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides","volume":"15","author":"RM de Voer","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/CDLI.11.2.272-279.2004","article-title":"Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135","volume":"11","author":"G Lal","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"PG van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"RG Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"ref31","first-page":"301","article-title":"Second national serum bank for population-based seroprevalence studies in the Netherlands","volume":"67","author":"FR van der Klis","year":"2009","journal-title":"Neth J Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/CVI.05354-11","article-title":"Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood","volume":"18","author":"A Khatami","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/INF.0b013e3181b9a831","article-title":"A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months","volume":"29","author":"J Diez-Domingo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/INF.0b013e31824f34e6","article-title":"Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom","volume":"31","author":"H Findlow","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"P Richmond","year":"2001","journal-title":"J Infect Dis"},{"key":"ref36","unstructured":"Vickers DM, Anonychuk AM, De Wals P, Demarteau N, Bauch CT (2013) Evaluation of serogroup C and ACWY meningococcal vaccine programs: Projected impact on disease burden according to a stochastic two-strain dynamic model. Vaccine."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom","volume":"71","author":"R Borrow","year":"2003","journal-title":"Infect Immun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e23497","DOI":"10.1371\/journal.pone.0023497","article-title":"Age-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgG","volume":"6","author":"RM de Voer","year":"2011","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/CVI.00241-06","article-title":"Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays","volume":"14","author":"SL Harris","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/338474","article-title":"Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults","volume":"185","author":"D Goldblatt","year":"2002","journal-title":"J Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0100651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T10:39:55Z","timestamp":1598006395000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0100651"}},"subtitle":[],"editor":[{"given":"Diane Medved","family":"Harper","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0100651","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]}}}